Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 23388678)

1.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.

J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.

2.

The medical management of opioid dependence in HIV primary care settings.

Lum PJ, Tulsky JP.

Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. Review.

PMID:
17089480
3.

Antiretroviral (ARV) drug resistance in the developing world.

Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, Newberry S.

Evid Rep Technol Assess (Full Rep). 2007 Sep;(156):1-74. Review.

4.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA.

Addiction. 2005 Feb;100(2):150-8. Review.

PMID:
15679744
5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
6.

Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Gruber VA, McCance-Katz EF.

Curr HIV/AIDS Rep. 2010 Aug;7(3):152-60. doi: 10.1007/s11904-010-0048-2. Review.

7.

Illicit drugs, alcohol, and addiction in human immunodeficiency virus.

Samet JH, Walley AY, Bridden C.

Panminerva Med. 2007 Jun;49(2):67-77. Review.

PMID:
17625483
8.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4. Review.

PMID:
21833948
9.

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Bruce RD, Moody DE, Altice FL, Gourevitch MN, Friedland GH.

Expert Rev Clin Pharmacol. 2013 May;6(3):249-69. doi: 10.1586/ecp.13.18. Review.

10.

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.

Bruce RD, Altice FL, Gourevitch MN, Friedland GH.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):563-72. Review.

PMID:
16652030
11.

Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Velasco-Hernandez JX, Gershengorn HB, Blower SM.

Lancet Infect Dis. 2002 Aug;2(8):487-93. Review.

PMID:
12150848
12.

Drug treatment as HIV prevention: a research update.

Metzger DS, Woody GE, O'Brien CP.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6. doi: 10.1097/QAI.0b013e3181f9c10b. Review.

13.

What do mathematical models tell us about the emergence and spread of drug-resistant HIV?

Baggaley RF, Powers KA, Boily MC.

Curr Opin HIV AIDS. 2011 Mar;6(2):131-40. doi: 10.1097/COH.0b013e328343ad03. Review.

14.

Drug treatment as HIV prevention: expanding treatment options.

Metzger DS, Zhang Y.

Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z. Review.

15.

Mitigating the risk of HIV infection with opioid substitution treatment.

Gowing LR, Hickman M, Degenhardt L.

Bull World Health Organ. 2013 Feb 1;91(2):148-9. doi: 10.2471/BLT.12.109553. Review. No abstract available.

16.

Association between knowledge of HIV-positive status or use of antiretroviral therapy and high-risk transmission behaviors: systematic review.

Zakher B, Blazina I, Chou R.

AIDS Care. 2014 Apr;26(4):514-21. doi: 10.1080/09540121.2013.832723. Epub 2013 Sep 5. Review.

PMID:
24007512
17.

Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Venkatesh KK, Flanigan TP, Mayer KH.

AIDS. 2011 Oct 23;25(16):1939-49. doi: 10.1097/QAD.0b013e32834b4ced. Review.

PMID:
21811137
18.

HIV Drug Resistance: Problems and Perspectives.

Pennings PS.

Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e5. doi: 10.4081/idr.2013.s1.e5. eCollection 2013 Jun 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk